Exact Mass: 366.2617

Exact Mass Matches: 366.2617

Found 56 metabolites which its exact mass value is equals to given mass value 366.2617, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Bepridil

N-benzyl-N-[3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl]aniline

C24H34N2O (366.2671)


Bepridil is only found in individuals that have used or taken this drug. It is a long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist. [PubChem]Bepridil has inhibitory effects on both the slow calcium (L-type) and fast sodium inward currents in myocardial and vascular smooth muscle, interferes with calcium binding to calmodulin, and blocks both voltage and receptor operated calcium channels. Bepridil inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. This has been demonstrated in isolated myocardial and vascular smooth muscle preparations in which both the slope of the calcium dose response curve and the maximum calcium-induced inotropic response were significantly reduced by bepridil. In cardiac myocytes in vitro, bepridil was shown to be tightly bound to actin. Bepridil regularly reduces heart rate and arterial pressure at rest and at a given level of exercise by dilating peripheral arterioles and reducing total peripheral resistance (afterload) against which the heart works. C - Cardiovascular system > C08 - Calcium channel blockers > C08E - Non-selective calcium channel blockers > C08EA - Phenylalkylamine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

Quingestanol

5-(cyclopentyloxy)-14-ethynyl-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-5,7-dien-14-ol

C25H34O2 (366.2559)


   

Apo-12'-zeaxanthinal

(2E,4E,6E,8E,10E,12E)-13-[(4R)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-2,7,11-trimethyltrideca-2,4,6,8,10,12-hexaenal

C25H34O2 (366.2559)


Apo-12-zeaxanthinal is a member of the class of compounds known as diterpenoids. Diterpenoids are terpene compounds formed by four isoprene units. Apo-12-zeaxanthinal is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Apo-12-zeaxanthinal can be found in a number of food items such as pepper (c. annuum), orange bell pepper, yellow bell pepper, and italian sweet red pepper, which makes apo-12-zeaxanthinal a potential biomarker for the consumption of these food products.

   

Magnesium caprate

magnesium(2+) ion didecanoate

C20H38MgO4 (366.262)


It is used as a food additive .

   

homo-Plakotenin

homo-Plakotenin

C25H34O2 (366.2559)


   

Granulatamide B

Granulatamide B

C24H34N2O (366.2671)


   

HEXAPROPYLENE GLYCOL

HEXAPROPYLENE GLYCOL

C18H38O7 (366.2617)


   

SCHEMBL21382326

SCHEMBL21382326

C25H34O2 (366.2559)


   

Ophiobolin G

Ophiobolin G

C25H34O2 (366.2559)


   
   

(4Z,7Z,10Z,13Z,16Z)-5-(nonadeca-4,7,10,13,16-pentaenyl)benzene-1,3-diol|(all-Z)-form-5-(4,7,10,13,16-Nonadecapentaenyl)-1,3-benzenediol

(4Z,7Z,10Z,13Z,16Z)-5-(nonadeca-4,7,10,13,16-pentaenyl)benzene-1,3-diol|(all-Z)-form-5-(4,7,10,13,16-Nonadecapentaenyl)-1,3-benzenediol

C25H34O2 (366.2559)


   

bepridil

BEPRIDIL HYDROCHLORIDE MONOHYDRATE

C24H34N2O (366.2671)


C - Cardiovascular system > C08 - Calcium channel blockers > C08E - Non-selective calcium channel blockers > C08EA - Phenylalkylamine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

5-((4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaen-1-yl)resorcinol

5-((4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaen-1-yl)benzene-1,3-diol

C25H34O2 (366.2559)


   
   

Diheptyl 1,2-(2H4)benzenedicarboxylate

Diheptyl 1,2-(2H4)benzenedicarboxylate

C22H30D4O4 (366.2708)


   

4-pentylphenyl 4-heptylbenzoate

4-pentylphenyl 4-heptylbenzoate

C25H34O2 (366.2559)


   

1,2,3-Trifluoro-5-[trans-4-[2-(trans-4-propylcyclohexyl)ethyl]cyclohexyl]benzene

1,2,3-Trifluoro-5-[trans-4-[2-(trans-4-propylcyclohexyl)ethyl]cyclohexyl]benzene

C23H33F3 (366.2534)


   

magnesium neodecanoate

magnesium neodecanoate

C20H38MgO4 (366.262)


   

1,2-BIS(DI-TERT-BUTYLPHOSPHINO)BENZENE

1,2-BIS(DI-TERT-BUTYLPHOSPHINO)BENZENE

C22H40P2 (366.2605)


   

Quingestanol

Quingestanol

C25H34O2 (366.2559)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   

3-Hydroxy-beta-apo-12-carotenal

3-Hydroxy-beta-apo-12-carotenal

C25H34O2 (366.2559)


   

(3R)-3-hydroxy-12-apo-beta-carotenal

(3R)-3-hydroxy-12-apo-beta-carotenal

C25H34O2 (366.2559)


An apo carotenoid C25 terpenoid compound consisting of 12-apo-beta-carotene having an aldehyde group in the 12-position and an (R)-hydroxy substituent at the 3-position.

   

[3-carboxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(7E,9E,11E)-tetradeca-7,9,11-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(7E,9E,11E)-tetradeca-7,9,11-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(3E,5E,7E)-tetradeca-3,5,7-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(3E,5E,7E)-tetradeca-3,5,7-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(8E,10E,12E)-tetradeca-8,10,12-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8E,10E,12E)-tetradeca-8,10,12-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(4E,7E,10E)-tetradeca-4,7,10-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(4E,7E,10E)-tetradeca-4,7,10-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(4E,6E,8E)-tetradeca-4,6,8-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(4E,6E,8E)-tetradeca-4,6,8-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(6E,9E,12E)-tetradeca-6,9,12-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(6E,9E,12E)-tetradeca-6,9,12-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(5E,7E,9E)-tetradeca-5,7,9-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5E,7E,9E)-tetradeca-5,7,9-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(2E,5E,8E)-tetradeca-2,5,8-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(2E,5E,8E)-tetradeca-2,5,8-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(6E,8E,10E)-tetradeca-6,8,10-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(6E,8E,10E)-tetradeca-6,8,10-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(4E,10E,12E)-tetradeca-4,10,12-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(4E,10E,12E)-tetradeca-4,10,12-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(3E,6E,9E)-tetradeca-3,6,9-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(3E,6E,9E)-tetradeca-3,6,9-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

[3-carboxy-2-[(2E,4E,6E)-tetradeca-2,4,6-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(2E,4E,6E)-tetradeca-2,4,6-trienoyl]oxypropyl]-trimethylazanium

C21H36NO4+ (366.2644)


   

wortmanamide A(1-)

wortmanamide A(1-)

C21H36NO4- (366.2644)


   

N-[(3-methoxyphenyl)methyl]-N-methyl-1-[1-[2-(2-methylphenyl)ethyl]-3-piperidinyl]methanamine

N-[(3-methoxyphenyl)methyl]-N-methyl-1-[1-[2-(2-methylphenyl)ethyl]-3-piperidinyl]methanamine

C24H34N2O (366.2671)


   
   

(1r,3s,7s,8e,11s,12r)-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

(1r,3s,7s,8e,11s,12r)-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

C25H34O2 (366.2559)


   

(2s)-n-[(3r,5r,6s)-7-[(4s)-4-ethenyl-4,5-dihydro-1,3-thiazol-2-yl]-3,5,6-trimethylheptyl]-n,2-dimethylbutanamide

(2s)-n-[(3r,5r,6s)-7-[(4s)-4-ethenyl-4,5-dihydro-1,3-thiazol-2-yl]-3,5,6-trimethylheptyl]-n,2-dimethylbutanamide

C21H38N2OS (366.2705)


   

(2z,4e)-n-[2-(1h-indol-3-yl)ethyl]-3,5-dimethyldodeca-2,4-dienimidic acid

(2z,4e)-n-[2-(1h-indol-3-yl)ethyl]-3,5-dimethyldodeca-2,4-dienimidic acid

C24H34N2O (366.2671)


   

(2e)-3-[(1r,3r,3ar,4s,5s,7ar)-4,7-diethyl-1,3-dimethyl-5-phenyl-1,2,3,3a,5,7a-hexahydroinden-4-yl]-2-methylprop-2-enoic acid

(2e)-3-[(1r,3r,3ar,4s,5s,7ar)-4,7-diethyl-1,3-dimethyl-5-phenyl-1,2,3,3a,5,7a-hexahydroinden-4-yl]-2-methylprop-2-enoic acid

C25H34O2 (366.2559)


   

1,4-dimethyl-12-(6-methylhepta-3,5-dien-2-yl)-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

1,4-dimethyl-12-(6-methylhepta-3,5-dien-2-yl)-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

C25H34O2 (366.2559)


   

(2e,4e,6z,8e,10e,12e)-13-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-2,7,11-trimethyltrideca-2,4,6,8,10,12-hexaenal

(2e,4e,6z,8e,10e,12e)-13-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-2,7,11-trimethyltrideca-2,4,6,8,10,12-hexaenal

C25H34O2 (366.2559)


   

n-[7-(4-ethenyl-4,5-dihydro-1,3-thiazol-2-yl)-3,5,6-trimethylheptyl]-n,2-dimethylbutanamide

n-[7-(4-ethenyl-4,5-dihydro-1,3-thiazol-2-yl)-3,5,6-trimethylheptyl]-n,2-dimethylbutanamide

C21H38N2OS (366.2705)


   

(2e)-3-[(1r,3r,3as,4r,5r,7as)-4,7-diethyl-1,3-dimethyl-5-phenyl-1,2,3,3a,5,7a-hexahydroinden-4-yl]-2-methylprop-2-enoic acid

(2e)-3-[(1r,3r,3as,4r,5r,7as)-4,7-diethyl-1,3-dimethyl-5-phenyl-1,2,3,3a,5,7a-hexahydroinden-4-yl]-2-methylprop-2-enoic acid

C25H34O2 (366.2559)


   

(1r,3s,7r,8e,11s,12r)-1,4-dimethyl-12-[(2s,3e)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

(1r,3s,7r,8e,11s,12r)-1,4-dimethyl-12-[(2s,3e)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

C25H34O2 (366.2559)


   

(1r,3s,7r,8e,11s,12r)-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

(1r,3s,7r,8e,11s,12r)-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

C25H34O2 (366.2559)


   

9-(1,6-dimethyl-2-propyl-4a,5,8,8a-tetrahydro-2h-naphthalen-1-yl)-8-methylnona-2,4,6,8-tetraenoic acid

9-(1,6-dimethyl-2-propyl-4a,5,8,8a-tetrahydro-2h-naphthalen-1-yl)-8-methylnona-2,4,6,8-tetraenoic acid

C25H34O2 (366.2559)


   

(4e,6e,8e,10e,12e)-13-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-2,7,11-trimethyltrideca-2,4,6,8,10,12-hexaenal

(4e,6e,8e,10e,12e)-13-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-2,7,11-trimethyltrideca-2,4,6,8,10,12-hexaenal

C25H34O2 (366.2559)


   

(2e,4e,6e,8e)-9-[(1r,2r,4as,8ar)-1,6-dimethyl-2-propyl-4a,5,8,8a-tetrahydro-2h-naphthalen-1-yl]-8-methylnona-2,4,6,8-tetraenoic acid

(2e,4e,6e,8e)-9-[(1r,2r,4as,8ar)-1,6-dimethyl-2-propyl-4a,5,8,8a-tetrahydro-2h-naphthalen-1-yl]-8-methylnona-2,4,6,8-tetraenoic acid

C25H34O2 (366.2559)


   

(1r,4r,11s,12r)-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-3(7),8-diene-8-carbaldehyde

(1r,4r,11s,12r)-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-3(7),8-diene-8-carbaldehyde

C25H34O2 (366.2559)


   

13-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-2,7,11-trimethyltrideca-2,4,6,8,10,12-hexaenal

13-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-2,7,11-trimethyltrideca-2,4,6,8,10,12-hexaenal

C25H34O2 (366.2559)


   

3-(4,7-diethyl-1,3-dimethyl-5-phenyl-1,2,3,3a,5,7a-hexahydroinden-4-yl)-2-methylprop-2-enoic acid

3-(4,7-diethyl-1,3-dimethyl-5-phenyl-1,2,3,3a,5,7a-hexahydroinden-4-yl)-2-methylprop-2-enoic acid

C25H34O2 (366.2559)


   

1,4-dimethyl-12-(6-methylhepta-3,5-dien-2-yl)-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-3(7),8-diene-8-carbaldehyde

1,4-dimethyl-12-(6-methylhepta-3,5-dien-2-yl)-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-3(7),8-diene-8-carbaldehyde

C25H34O2 (366.2559)